Latest Articles

Publication Date
Aprea reports second partial response in endometrial cancer trial By Investing.com - Investing.com South Africa

Aprea reports second partial response in endometrial cancer trial By Investing.com Investing.com South Africa

Published: Feb. 19, 2026, 12:54 a.m.
Brenner tumor associated with mucinous cyst and endometriosis: a case report.

Brenner tumors are rare ovarian neoplasms that often coexist with other epithelial tumors, most commonly mucinous cystic neoplasms. The association of Brenner tumors with endometriosis is unusual and not well-documented …

Published: Feb. 19, 2026, midnight
Aprea reports second partial response in endometrial cancer trial - Investing.com Nigeria

Aprea reports second partial response in endometrial cancer trial Investing.com Nigeria

Published: Feb. 18, 2026, 11:46 p.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com

Aprea reports second partial response in endometrial cancer trial Investing.com

Published: Feb. 18, 2026, 1:42 p.m.
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - European Medical Journal

GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk European Medical Journal

Published: Feb. 18, 2026, noon
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - EMJ | Elevating the quality of healthcare globally

GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk EMJ | Elevating the quality of healthcare globally

Published: Feb. 18, 2026, noon
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... - Medical Dialogues

Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... Medical Dialogues

Published: Feb. 17, 2026, 3:15 p.m.
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia - 2 Minute Medicine

Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia 2 Minute Medicine

Published: Feb. 17, 2026, 12:15 a.m.
Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer - Daily Mail

Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer Daily Mail

Published: Feb. 16, 2026, 1:01 p.m.
Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer - dailymail.co.uk

Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer dailymail.co.uk

Published: Feb. 16, 2026, 1:01 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!